CAS 315705-75-0

Jnj0966

CAS : 315705-75-0

Formule : C₁₆H₁₆N₄O₂S₂

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 360.4538

Ref: IN-DA01EOFE

N-(2-((2-Methoxyphenyl)Amino)-4'-Methyl-[4,5'-Bithiazol]-2'-Yl)Acetamide

CAS : 315705-75-0

N-(2-((2-Methoxyphenyl)Amino)-4'-Methyl-[4,5'-Bithiazol]-2'-Yl)Acetamide

Degré de pureté : 99%

Masse moléculaire : 360.45g/mol

Ref: 54-OR1023177

JNJ0966

CAS : 315705-75-0

JNJ0966

Degré de pureté : ≥98%

Masse moléculaire : 360.45g/mol

Ref: 54-BUP12550

JNJ0966

CAS : 315705-75-0

JNJ0966 is a highly selective MMP-9 zymogen inhibitor (IC50: 440 nM).

Formule : C₁₆H₁₆N₄O₂S₂

Degré de pureté : 99.46% - 99.62%

Couleur et forme : Solid

Masse moléculaire : 360.45

Ref: TM-T4783

JNJ0966

CAS : 315705-75-0

JNJ0966 is a zymogen that has been shown to be activated after cleavage by trypsin and enterokinase. It inhibits the activity of epidermal growth factor (EGF) and its receptor, EGFR, as well as other growth factors. JNJ0966 blocks the kinase signaling pathways in cells and prevents the phosphorylation of tyrosine residues on proteins that are involved in cell proliferation, survival, and differentiation. JNJ0966 has been shown to inhibit tumor growth in vitro and in vivo. This drug also possesses anti-inflammatory properties, which may stem from inhibition of cytokines such as IL-2 or TNF-α.

Formule : C₁₆H₁₆N₄O₂S₂

Degré de pureté : Min. 95%

Masse moléculaire : 360.45 g/mol

Ref: 3D-QMA70575